Gemcitabine Hemolytic Uremic Syndrome (HUS) Associated with a New Complement Factor B (CFB) Mutation Successfully Treated with Eculizumab

Stephanie Lawanto, Gregory L Braden + Show 3 more

https://doi.org/10.1681/asn.20233411s1482b

Copy DOI

Publication Date: Nov 1, 2023

Abstract

Gemcitabine Hemolytic Uremic Syndrome (HUS) Associated with a New Complement Factor B (CFB) Mutation Successfully Treated with Eculizumab

Full Text

Paper version not known

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author